ROBERT STEVENS: Open Payments
NPI 1689767105 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,976 in 101 payments from 13 companies in 2025. Trend: 2023 $1,299 · 2024 $1,749 · 2025 $1,976
Food & beverage: $1,976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $345 |
| Janssen Biotech, Inc. | 20 | $310 |
| Novartis Pharmaceuticals Corporation | 14 | $297 |
| Lilly USA, LLC | 9 | $218 |
| GENZYME CORPORATION | 6 | $212 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $170 |
| LEO Pharma Inc. | 7 | $144 |
| UCB, Inc. | 6 | $102 |
| Incyte Corporation | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
Products named: TREMFYA, COSENTYX, DUPIXENT, TALTZ, SKYRIZI, ILUMYA, RINVOQ, ADBRY.
Industry payments across AR — which companies pay providers there.
